IBB vs. BITI
IBB (iShares Nasdaq Biotechnology ETF) and BITI (ProShares Short Bitcoin ETF) are both exchange-traded funds - IBB is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while BITI is a Cryptocurrency fund tracking the Bloomberg Bitcoin Index. Both are passively managed. Over the past 3 years, IBB returned 13.65%/yr vs -31.77%/yr for BITI. Their -0.29 correlation means they have often moved in opposite directions in the past. IBB charges 0.47%/yr vs 1.03%/yr for BITI.
Performance
IBB vs. BITI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBB achieves a 10.55% return, which is significantly lower than BITI's 27.11% return.
IBB
- 1D
- -1.87%
- 1M
- -4.75%
- 6M
- 8.20%
- YTD
- 10.55%
- 1Y
- 40.47%
- 3Y*
- 13.65%
- 5Y*
- 2.65%
- 10Y*
- 6.89%
- ALL TIME*
- 7.16%
BITI
- 1D
- 3.01%
- 1M
- -2.58%
- 6M
- 22.77%
- YTD
- 27.11%
- 1Y
- 58.64%
- 3Y*
- -31.77%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -35.65%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $24.10M | $26.49M | $38.71M | |
| $252.83M | $308.82M | $278.87M |
IBB vs. BITI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 10.55% | 27.98% | -2.41% | 3.76% | 20.09% |
BITI ProShares Short Bitcoin ETF | 27.11% | -1.76% | -62.60% | -66.17% | 3.39% |
Correlation
The correlation between IBB and BITI is -0.29, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.29 |
Correlation (3Y) Balances recent behavior with more history. | -0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 21, 2022 | -0.29 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. BITI — Risk / Return Rank
IBB
BITI
IBB vs. BITI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and ProShares Short Bitcoin ETF (BITI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBB | BITI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.56 | ||
| Sortino ratioReturn per unit of downside risk | +0.78 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.24 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 4.25 | 2.53 | +1.72 |
| Martin ratioReturn relative to average drawdown | 12.35 | 6.17 | +6.18 |
Loading charts...
Drawdowns
IBB vs. BITI - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, smaller than the maximum BITI drawdown of -92.16%. Use the drawdown chart below to compare losses from any high point for IBB and BITI.
Loading charts...
Drawdown Indicators
| IBB | BITI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -92.16% | +29.31% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -25.28% | +15.65% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -84.63% | +59.78% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | — | — |
Current DrawdownCurrent decline from peak | -5.96% | -86.12% | +80.16% |
Average DrawdownAverage peak-to-trough decline | -21.06% | -68.59% | +47.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.31% | 10.35% | -7.04% |
Volatility
IBB vs. BITI - Volatility Comparison
The current volatility for iShares Nasdaq Biotechnology ETF (IBB) is 6.14%, while ProShares Short Bitcoin ETF (BITI) has a volatility of 9.13%. This indicates that IBB experiences smaller price fluctuations and is considered to be less risky than BITI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | BITI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.14% | 9.13% | -2.99% |
Volatility (6M)Calculated over the trailing 6-month period | 15.87% | 33.31% | -17.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.45% | 44.23% | -23.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.12% | 52.03% | -29.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.12% | 52.03% | -28.91% |
IBB vs. BITI - Expense Ratio Comparison
IBB has a 0.47% expense ratio, which is lower than BITI's 1.03% expense ratio.
Dividends
IBB vs. BITI - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.22%, less than BITI's 15.30% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BITI ProShares Short Bitcoin ETF | 15.17% | 1.60% | 3.91% | 3.33% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.22% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
IBB and BITI have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BITI has higher volatility (9.13%) compared to IBB (6.14%). In terms of maximum drawdown, IBB dropped -62.85% vs BITI's -92.16%.
On 3-year performance, IBB leads with 13.65% vs -31.77% for BITI. On fees, IBB is cheaper at 0.47% per year. On volatility, IBB has been the lower-risk option at 6.14%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IBB has performed better with a 13.65% return vs -31.77%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBB is cheaper with a 0.47% expense ratio, compared with 1.03% for BITI.
BITI has the higher dividend yield at 15.17%, compared with 0.22% for IBB.
IBB is categorized as Health & Biotech Equities, while BITI is Cryptocurrency. IBB tracks NASDAQ Biotechnology Index, while BITI tracks Bloomberg Bitcoin Index. They also come from different issuers: iShares and ProShares. Their fees differ too: 0.47% for IBB and 1.03% for BITI.
IBB currently has the higher Sharpe Ratio (2.00 vs 1.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and BITI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer